- Home
- PML vs PAHC Comparison
PML vs PAHC Comparison
Compare PML & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PML
- PAHC
- Stock Information
- Founded
- PML 2002
- PAHC 1946
- Country
- PML United States
- PAHC United States
- Employees
- PML N/A
- PAHC N/A
- Industry
- PML Investment Managers
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- PML Finance
- PAHC Health Care
- Exchange
- PML Nasdaq
- PAHC Nasdaq
- Market Cap
- PML 581.8M
- PAHC 682.5M
- IPO Year
- PML N/A
- PAHC 2014
- Fundamental
- Price
- PML $8.24
- PAHC $20.52
- Analyst Decision
- PML
- PAHC Sell
- Analyst Count
- PML 0
- PAHC 4
- Target Price
- PML N/A
- PAHC $20.50
- AVG Volume (30 Days)
- PML 188.0K
- PAHC 185.1K
- Earning Date
- PML 01-01-0001
- PAHC 02-05-2025
- Dividend Yield
- PML 5.65%
- PAHC 2.33%
- EPS Growth
- PML N/A
- PAHC N/A
- EPS
- PML N/A
- PAHC 0.43
- Revenue
- PML N/A
- PAHC $1,046,762,000.00
- Revenue This Year
- PML N/A
- PAHC $27.25
- Revenue Next Year
- PML N/A
- PAHC $14.13
- P/E Ratio
- PML N/A
- PAHC $47.75
- Revenue Growth
- PML N/A
- PAHC 7.17
- 52 Week Low
- PML $6.92
- PAHC $10.04
- 52 Week High
- PML $9.46
- PAHC $25.98
- Technical
- Relative Strength Index (RSI)
- PML 41.79
- PAHC 29.59
- Support Level
- PML $7.97
- PAHC $20.24
- Resistance Level
- PML $8.81
- PAHC $21.23
- Average True Range (ATR)
- PML 0.13
- PAHC 0.80
- MACD
- PML 0.02
- PAHC -0.14
- Stochastic Oscillator
- PML 52.68
- PAHC 7.69
About PML Pimco Municipal Income Fund II of Beneficial Interest
PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.